World News: 21:05 GMT Friday 10th August 2018. [OrthoPediatrics Corp. via Globe Newswire via SPi World News]
WARSAW, Ind., Aug. 10, 2018 (GLOBE NEWSWIRE) -- (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to participate in the Pediatric Medical Device Development Public Meeting, organized by the U.S. Food & Drug Administration (“FDA”). The conference will take place at the FDA’s White Oak Campus in suburban Washington D.C. on August 13-14, 2018.
OrthoPediatrics’ President & CEO, Mark Throdahl, will present on the “Small Company Business Model”, during which he will describe the Company’s business model and evolution. He will then participate on an Expert Panel discussion titled, “The Next 10 Years: Toward a Modern Medical Device Ecosystem for Adults and Children.” In addition, OrthoPediatrics’ Chief Medical Office, Dr. Peter F. Armstrong, will address the conference during a “Public Comment Presentation” on pediatric medical device development.
Mr. Throdahl commented, “We are honored to participate in this year’s event as the only orthopedic company that has successfully built a business exclusively focused on pediatric devices. We applaud and support the FDA’s efforts to stimulate the development of pediatric specific medical devices, and we look forward to continued collaboration with the organization.”
Globe Newswire: 21:05 GMT Friday 10th August 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.